nodes	percent_of_prediction	percent_of_DWPC	metapath
Lubiprostone—CLCN2—Stimuli-sensing channels—CLCN5—nephrolithiasis	0.111	0.181	CbGpPWpGaD
Lubiprostone—CLCN2—Stimuli-sensing channels—CLCN4—nephrolithiasis	0.111	0.181	CbGpPWpGaD
Lubiprostone—Fibromyalgia—Hydrochlorothiazide—nephrolithiasis	0.0922	0.237	CcSEcCtD
Lubiprostone—CLCN2—Ion channel transport—CLCN4—nephrolithiasis	0.0722	0.118	CbGpPWpGaD
Lubiprostone—CLCN2—Ion channel transport—CLCN5—nephrolithiasis	0.0722	0.118	CbGpPWpGaD
Lubiprostone—Electrolyte imbalance—Hydrochlorothiazide—nephrolithiasis	0.0277	0.0713	CcSEcCtD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.0251	0.0411	CbGpPWpGaD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.0251	0.0411	CbGpPWpGaD
Lubiprostone—Joint swelling—Hydrochlorothiazide—nephrolithiasis	0.0236	0.0607	CcSEcCtD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.0224	0.0366	CbGpPWpGaD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.0205	0.0335	CbGpPWpGaD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.0205	0.0335	CbGpPWpGaD
Lubiprostone—CBR1—NRF2 pathway—SLC2A9—nephrolithiasis	0.0193	0.0316	CbGpPWpGaD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.0155	0.0254	CbGpPWpGaD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.0155	0.0254	CbGpPWpGaD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.0144	0.0236	CbGpPWpGaD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.0144	0.0236	CbGpPWpGaD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.0129	0.021	CbGpPWpGaD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.0129	0.021	CbGpPWpGaD
Lubiprostone—Gastrooesophageal reflux disease—Hydrochlorothiazide—nephrolithiasis	0.0128	0.033	CcSEcCtD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.0103	0.0168	CbGpPWpGaD
Lubiprostone—Swelling—Hydrochlorothiazide—nephrolithiasis	0.00951	0.0245	CcSEcCtD
Lubiprostone—Cramp muscle—Hydrochlorothiazide—nephrolithiasis	0.00755	0.0195	CcSEcCtD
Lubiprostone—Aspartate aminotransferase increased—Hydrochlorothiazide—nephrolithiasis	0.00755	0.0195	CcSEcCtD
Lubiprostone—Gastritis—Hydrochlorothiazide—nephrolithiasis	0.00742	0.0191	CcSEcCtD
Lubiprostone—Alanine aminotransferase increased—Hydrochlorothiazide—nephrolithiasis	0.0074	0.0191	CcSEcCtD
Lubiprostone—Abdominal distension—Hydrochlorothiazide—nephrolithiasis	0.0073	0.0188	CcSEcCtD
Lubiprostone—Influenza—Hydrochlorothiazide—nephrolithiasis	0.00725	0.0187	CcSEcCtD
Lubiprostone—Pollakiuria—Hydrochlorothiazide—nephrolithiasis	0.0067	0.0173	CcSEcCtD
Lubiprostone—Weight increased—Hydrochlorothiazide—nephrolithiasis	0.0066	0.017	CcSEcCtD
Lubiprostone—Urinary tract infection—Hydrochlorothiazide—nephrolithiasis	0.00628	0.0162	CcSEcCtD
Lubiprostone—Oedema peripheral—Hydrochlorothiazide—nephrolithiasis	0.00572	0.0147	CcSEcCtD
Lubiprostone—Erythema—Hydrochlorothiazide—nephrolithiasis	0.00505	0.013	CcSEcCtD
Lubiprostone—Flatulence—Hydrochlorothiazide—nephrolithiasis	0.00498	0.0128	CcSEcCtD
Lubiprostone—Dysgeusia—Hydrochlorothiazide—nephrolithiasis	0.00495	0.0127	CcSEcCtD
Lubiprostone—Muscle spasms—Hydrochlorothiazide—nephrolithiasis	0.00486	0.0125	CcSEcCtD
Lubiprostone—Tremor—Hydrochlorothiazide—nephrolithiasis	0.00473	0.0122	CcSEcCtD
Lubiprostone—Ill-defined disorder—Hydrochlorothiazide—nephrolithiasis	0.00469	0.0121	CcSEcCtD
Lubiprostone—Malaise—Hydrochlorothiazide—nephrolithiasis	0.00456	0.0117	CcSEcCtD
Lubiprostone—Syncope—Hydrochlorothiazide—nephrolithiasis	0.00453	0.0117	CcSEcCtD
Lubiprostone—Palpitations—Hydrochlorothiazide—nephrolithiasis	0.00446	0.0115	CcSEcCtD
Lubiprostone—Loss of consciousness—Hydrochlorothiazide—nephrolithiasis	0.00444	0.0114	CcSEcCtD
Lubiprostone—Cough—Hydrochlorothiazide—nephrolithiasis	0.00441	0.0114	CcSEcCtD
Lubiprostone—Myalgia—Hydrochlorothiazide—nephrolithiasis	0.0043	0.0111	CcSEcCtD
Lubiprostone—Chest pain—Hydrochlorothiazide—nephrolithiasis	0.0043	0.0111	CcSEcCtD
Lubiprostone—Anxiety—Hydrochlorothiazide—nephrolithiasis	0.00429	0.011	CcSEcCtD
Lubiprostone—Discomfort—Hydrochlorothiazide—nephrolithiasis	0.00425	0.0109	CcSEcCtD
Lubiprostone—Dry mouth—Hydrochlorothiazide—nephrolithiasis	0.00421	0.0108	CcSEcCtD
Lubiprostone—Oedema—Hydrochlorothiazide—nephrolithiasis	0.00412	0.0106	CcSEcCtD
Lubiprostone—Shock—Hydrochlorothiazide—nephrolithiasis	0.00406	0.0104	CcSEcCtD
Lubiprostone—Tachycardia—Hydrochlorothiazide—nephrolithiasis	0.00402	0.0104	CcSEcCtD
Lubiprostone—Hyperhidrosis—Hydrochlorothiazide—nephrolithiasis	0.00399	0.0103	CcSEcCtD
Lubiprostone—Anorexia—Hydrochlorothiazide—nephrolithiasis	0.00393	0.0101	CcSEcCtD
Lubiprostone—CBR1—Metabolism—GRHPR—nephrolithiasis	0.00382	0.00625	CbGpPWpGaD
Lubiprostone—Musculoskeletal discomfort—Hydrochlorothiazide—nephrolithiasis	0.00376	0.00968	CcSEcCtD
Lubiprostone—Dyspnoea—Hydrochlorothiazide—nephrolithiasis	0.00368	0.00947	CcSEcCtD
Lubiprostone—Dyspepsia—Hydrochlorothiazide—nephrolithiasis	0.00363	0.00935	CcSEcCtD
Lubiprostone—Decreased appetite—Hydrochlorothiazide—nephrolithiasis	0.00358	0.00923	CcSEcCtD
Lubiprostone—Fatigue—Hydrochlorothiazide—nephrolithiasis	0.00355	0.00916	CcSEcCtD
Lubiprostone—Pain—Hydrochlorothiazide—nephrolithiasis	0.00353	0.00908	CcSEcCtD
Lubiprostone—Constipation—Hydrochlorothiazide—nephrolithiasis	0.00353	0.00908	CcSEcCtD
Lubiprostone—CBR1—Metabolism—AGXT—nephrolithiasis	0.00341	0.00557	CbGpPWpGaD
Lubiprostone—Feeling abnormal—Hydrochlorothiazide—nephrolithiasis	0.0034	0.00875	CcSEcCtD
Lubiprostone—Gastrointestinal pain—Hydrochlorothiazide—nephrolithiasis	0.00337	0.00868	CcSEcCtD
Lubiprostone—Abdominal pain—Hydrochlorothiazide—nephrolithiasis	0.00326	0.00839	CcSEcCtD
Lubiprostone—Hypersensitivity—Hydrochlorothiazide—nephrolithiasis	0.00304	0.00782	CcSEcCtD
Lubiprostone—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.00296	0.00762	CcSEcCtD
Lubiprostone—CBR1—Metabolism—APRT—nephrolithiasis	0.0029	0.00474	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—SLC26A1—nephrolithiasis	0.0029	0.00474	CbGpPWpGaD
Lubiprostone—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.00282	0.00727	CcSEcCtD
Lubiprostone—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.00273	0.00702	CcSEcCtD
Lubiprostone—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.00262	0.00675	CcSEcCtD
Lubiprostone—Rash—Hydrochlorothiazide—nephrolithiasis	0.0026	0.0067	CcSEcCtD
Lubiprostone—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.0026	0.00669	CcSEcCtD
Lubiprostone—Headache—Hydrochlorothiazide—nephrolithiasis	0.00258	0.00665	CcSEcCtD
Lubiprostone—Nausea—Hydrochlorothiazide—nephrolithiasis	0.00245	0.00631	CcSEcCtD
Lubiprostone—CBR1—Metabolism—AQP1—nephrolithiasis	0.00206	0.00337	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—CHRM3—nephrolithiasis	0.00187	0.00305	CbGpPWpGaD
